X0306 4 2013-08-27 0 0001368993 WaferGen Bio-systems, Inc. WGBS 0001008231 KANTER JOEL S C/O WAFERGEN BIO-SYSTEMS, INC. 7400 PASEO PADRE PARKWAY FREMONT CA 94555 1 0 0 0 Common Stock 2013-08-27 4 A 0 28087 A 28389 D Common Stock 2013-08-27 4 A 0 14044 A 14799 I By Kanter Family Foundation Common Stock 2013-08-27 4 A 0 5000 A 33389 D Common Stock 2013-08-27 4 A 0 25000 A 39799 I By Kanter Family Foundation Series A-1 convertible Preferred Stock 2013-08-27 4 D 0 9615.38 D Common Stock 967 0 D Common Stock Warrant (right to buy) 61.62 2013-08-27 4 D 0 1851 D Common Stock 1851 0 D Convertible Promissory Note due 11/27/2014 56.65 2013-08-27 4 D 0 55924 D Common Stock 987 0 D Series A-1 Convertible Preferred Stock 2013-08-27 4 D 0 4807.39 D Common Stock 484 0 I By Kanter Family Foundation Common Stock Warrant (right to buy) 61.62 2013-08-27 4 D 0 926 D Common Stock 926 0 I By Kanter Family Foundation Convertible Promissory Note due 11/27/2014 56.65 2013-08-27 4 D 0 27962 D Common Stock 494 0 I By Kanter Family Foundation Common Stock Warrant (right to buy) 2.60 2013-08-27 4 A 0 7755 A 2013-08-27 2018-08-27 Common Stock 7755 7755 D Common Stock Warrant (right to buy) 2.60 2013-08-27 4 A 0 3877 A 2013-08-27 2018-08-27 Common Stock 3877 3877 I By Kanter Family Foundation Common Stock Warrant (right to buy) 2.60 2013-08-27 4 A 0 2500 A 2013-08-27 2018-08-27 Common Stock 2500 2500 D Common Stock Warrant (right to buy) 2.60 2013-08-27 4 A 0 12500 A 2013-08-27 2018-08-27 Common Stock 12500 12500 I By Kanter Family Foundation The securities were convertible into common stock at any time following their issuance on May 27, 2011, on a 9.939-for-1 basis, and had no expiration date. The reporting person disposed of 9,615.38 shares of Series A-1 convertible preferred stock, 1,851 common stock warrants and a convertible promissory note with a principal amount of $55,924, including accrued interest, in exchange for 28,087 shares of common stock and 7,755 common stock warrants in an issuer exchange transaction. The securities were convertible into common stock at any time following their issuance on May 27, 2011, until their expiry five years thereafter. The principal amount of the security includes interest earned from their issuance on May 27, 2011, up until August 27, 2013, and was convertible into Series A-2 convertible preferred stock, in whole or in part, at any time following their issuance, from time to time, with no expiration date. Each share of Series A-2 convertible preferred stock was convertible into common stock at any time on a 9.939-for-1 basis, with no expiration date. The Kanter Family Foundation disposed of 4,807.69 shares of Series A-1 convertible preferred stock, 926 common stock warrants and a convertible promissory note with a principal amount of $27,962, including accrued interest, in exchange for 14,044 shares of common stock and 3,877 common stock warrants in an issuer exchange transaction. The reported securities are included within 0.2 Units acquired by the reporting person from the issuer in a private placement for $50,000 per Unit. Each Unit consists of twenty five thousand (25,000) shares of common stock and twelve thousand five hundred (12,500) warrants to purchase one share of common stock. The reported securities are included within 1.0 Units acquired by the Kanter Family Foundation from the issuer in a private placement for $50,000 per Unit. Each Unit consists of twenty five thousand (25,000) shares of common stock and twelve thousand five hundred (12,500) warrants to purchase one share of common stock. On August 27, 2013, the common stock of WaferGen Bio-systems, Inc. was subject to a 1-for-99.39 reverse split. All dispositions, acquisitions and conversion ratios are recorded on a post-split basis. /s/ Joel Kanter 2013-08-29